Protease inhibitors - Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl- -alanine hydroxamate moieties

By Scozzafava A.   Ilies M.A.   Manole G.   Supuran C.T.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 1, 2000-07 ,pp. : 69-79

Elsevier

Access to resources Recommend Favorite

Entering the Era of Non-Basic P1 Site Groups: Discovery of Xarelto™ (Rivaroxaban)

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-02 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 7, 2016-08 ,pp. : 691-696

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors. Part 79 - Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties

By Mincione G.   Menabuoni L.   Briganti F.   Mincione F.   Scozzafava A.   Supuran C.T.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 2, 1999-12 ,pp. : 185-199

Elsevier

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors - Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: The first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV

By Supuran C.T.   Scozzafava A.   Ilies M.A.   Iorga B.   Cristea T.   Briganti F.   Chiraleu F.   Banciu M.D.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 7, 1998-07 ,pp. : 577-594

Elsevier

Access to resources Recommend Favorite